Watson 372 50 mg (Loxapine 50 mg)
Pill imprint Watson 372 50 mg has been identified as Loxapine succinate 50 mg.
Loxapine is used in the treatment of agitation; schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 50 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 50 mg
- Blue & White
- 19.00 mm
- Prescription only
edetate calcium disodium
sodium lauryl sulfate
FD&C Blue No. 1
|NDC Code||Manufacturer / Repackager|
|51079-0903||UDL Laboratories Inc|
Note: Inactive ingredients may vary.
More about loxapine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.